Abstract:Tumor-associated macrophages (TAMs) represent a key factor in the tumor immune microenvironment (TME), exerting significant influence over tumor migration, invasion, immunosuppressive features, and drug resistance. Collagen triple helix repeat containing 1 (CTHRC1), a 30 KDa protein which was secreted during the tissue-repair process, is highly expressed in several malignant tumors, including colorectal cancer (CRC). Previous studies demonstrated that CTHRC1 expression in TAMs was positively correlated to M2 macrophage polarization and liver metastasis, while our discovery suggesting a novel mechanism that CTHRC1 secreted from cancer cell could indirectly interplay with TAMs. In this study, the high expression level of CTHRC1 was evaluated in CRC based on GEO and TCGA databases. Further, CTHRC1 was detected high in all stages of CRC patients by ELISA and was correlated to poor prognosis. Multispectral imaging of IHC demonstrated that M2 macrophage infiltration was increased accompanied with CTHRC1 enrichment, suggesting that CTHRC1 may have chemotactic effect on macrophages. In vitro, CTHRC1 could have chemotactic ability of macrophage in the presence of HT-29 cell line. Cytokine microarray revealed that CTHRC1 could up-regulate the CCL15 level of HT-29, pathway analysis demonstrated that CTHRC1 could regulate CCL15 by controlling the TGFβ activation and Smad phosphorylation level. In vivo, knocking down of CTHRC1 from CT-26 also inhibits tumor formation. In conclusion, CTHRC1 could promote the chemotactic ability of macrophages by up-regulating CCL15 via TGFβ/Smad pathway; additionally, a high level of CTHRC1 could promote macrophage's M2 polarization. This discovery may be related to tumor immune tolerance and tumor immunotherapy resistance in CRC. KEY MESSAGES: CTHRC1 promotes CRC progression by up-regulating CCL15 via TGF-β/Smad pathways to further recruit tumor-associated macrophages. By the means of autocrine or paracrine, CTHRC1 can indeed promote macrophage chemotaxis and enhance the infiltration of macrophages in tumor tissues but in the presence of tumor cells. CAFs were another source of CTHRC1, indicating CTHRC1 can infiltrate tumor islet as well as the stomal and be secreted from both tumor cells and CAFs. This study validated CTHRC1 as a potential immune therapy target CRC.

CTHRC1 Acts As a Prognostic Factor and Promotes Invasiveness of Gastrointestinal Stromal Tumors by Activating Wnt/PCP-Rho Signaling

CTHRC1 Overexpression Promotes Ectopic Endometrial Stromal Cell Proliferation, Migration and Invasion Via Activation of the Wnt/β-catenin Pathway

Cthrc1 Promotes Human Colorectal Cancer Cell Proliferation and Invasiveness by Activating Wnt/Pcp Signaling

The Role of CTHRC1 in Regulation of Multiple Signaling and Tumor Progression and Metastasis

CTHRC1 Induces Non-Small Cell Lung Cancer (NSCLC) Invasion Through Upregulating MMP-7/MMP-9

CCBE1 promotes GIST development through enhancing angiogenesis and mediating resistance to imatinib

CTHRC1 Overexpression Predicts Poor Survival and Enhances Epithelial‐mesenchymal Transition in Colorectal Cancer

Pan-cancer analysis combined with experiments predicts CTHRC1 as a therapeutic target for human cancers

Cst1 Promoted Gastric Cancer Migration And Invasion Through Activating Wnt Pathway

Altered Expression of ETV1 and Its Contribution to Tumorigenic Phenotypes in Gastrointestinal Stromal Tumors.

CTHRC1 is upregulated by promoter demethylation and transforming growth factor-β1 and may be associated with metastasis in human gastric cancer.

CTHRC1 promotes gastric cancer metastasis via HIF-1α/CXCR4 signaling pathway

CTHRC1 activates pro-tumorigenic signaling pathways in hepatocellular carcinoma

<i>CTHRC1</i>is upregulated by promoter demethylation and transforming growth factor-β1 and may be associated with metastasis in human gastric cancer

Overexpression of Collagen Triple Helix Repeat Containing 1 (CTHRC1) is Associated with Tumour Aggressiveness and Poor Prognosis in Human Non-Small Cell Lung Cancer.

Clinical and prognostic significance of CC chemokine receptor type 8 protein expression in gastrointestinal stromal tumors

Expression Of Shh Signaling Pathway Factors In Gastrointestinal Stromal Tumor Tissues And Their Associations With Clinical Pathological Factors

Knockdown of Collagen Triple Helix Repeat Containing 1 (CTHRC1) Inhibits Epithelial-Mesenchymal Transition and Cellular Migration in Glioblastoma Cells

Tenascin-C Expression is Significantly Associated with the Progression and Prognosis in Gastric GISTs.

CTHRC1 promotes colorectal cancer progression by recruiting tumor-associated macrophages via up-regulation of CCL15

CTHRC1 is associated with immune cell infiltration and functions as an adverse marker for prognosis in head and neck squamous cell carcinoma.